{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T03:30:09Z","timestamp":1792121409357,"version":"4.4.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,11,6]],"date-time":"2014-11-06T00:00:00Z","timestamp":1415232000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2014,11,6]],"date-time":"2014-11-06T00:00:00Z","timestamp":1415232000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Genes Immun"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1038\/gene.2014.60","type":"journal-article","created":{"date-parts":[[2014,11,6]],"date-time":"2014-11-06T09:56:44Z","timestamp":1415267804000},"page":"43-53","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Cervical cancer-associated promoter polymorphism affects akna expression levels"],"prefix":"10.1038","volume":"16","author":[{"given":"G A","family":"Mart\u00ednez-Nava","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Torres-Poveda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Lagunas-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Bahena-Rom\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M A","family":"Zurita-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Ort\u00edz-Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Garc\u00eda-Carranc\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Madrid-Marina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A I","family":"Burguete-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,6]]},"reference":[{"key":"BFgene201460_CR1","unstructured":"Globocan 2012 (IARC) Section of Cancer Information. Available at: http:\/\/globocan.iarc.fr\/Pages\/fact_sheets_cancer.aspx."},{"key":"BFgene201460_CR2","doi-asserted-by":"publisher","first-page":"3106","DOI":"10.1001\/jama.286.24.3106","volume":"286","author":"NF Schlecht","year":"2001","unstructured":"Schlecht NF, Kulaga S, Robitaille J, Ferreira S, Santos M, Miyamura RA et al. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA 2001; 286: 3106\u20133114.","journal-title":"JAMA"},{"key":"BFgene201460_CR3","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/ijc.11222","volume":"106","author":"V Dalstein","year":"2003","unstructured":"Dalstein V, Riethmuller D, Pretet JL, Le Bail Carval K, Sautiere JL, Carbillet JP et al. Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study. Int J Cancer 2003; 106: 396\u2013403.","journal-title":"Int J Cancer"},{"key":"BFgene201460_CR4","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1158\/1055-9965.EPI-10-0791","volume":"20","author":"RP Insinga","year":"2011","unstructured":"Insinga RP, Perez G, Wheeler CM, Koutsky LA, Garland SM, Leodolter S et al. Incident cervical HPV infections in young women: transition probabilities for CIN and infection clearance. Cancer Epidemiol Biomarkers Prev 2011; 20: 287\u2013296.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BFgene201460_CR5","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1002\/1097-0215(20001201)88:5<698::AID-IJC3>3.0.CO;2-J","volume":"88","author":"PK Magnusson","year":"2000","unstructured":"Magnusson PK, Lichtenstein P, Gyllensten UB. Heritability of cervical tumours. Int J Cancer 2000; 88: 698\u2013701.","journal-title":"Int J Cancer"},{"key":"BFgene201460_CR6","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1111\/1471-0528.12638","volume":"121","author":"X Zhang","year":"2014","unstructured":"Zhang X, Zhang L, Tian C, Yang L, Wang Z. Genetic variants and risk of cervical cancer: epidemiological evidence, meta-analysis and research review. BJOG 2014; 121: 664\u2013673.","journal-title":"BJOG"},{"key":"BFgene201460_CR7","doi-asserted-by":"publisher","first-page":"3351","DOI":"10.1093\/hmg\/ddl411","volume":"15","author":"MT Engelmark","year":"2006","unstructured":"Engelmark MT, Ivansson EL, Magnusson JJ, Gustavsson IM, Beskow AH, Magnusson PK et al. Identification of susceptibility loci for cervical carcinoma by genome scan of affected sib-pairs. Hum Mol Genet 2006; 15: 3351\u20133360.","journal-title":"Hum Mol Genet"},{"key":"BFgene201460_CR8","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1038\/35066602","volume":"410","author":"A Siddiqa","year":"2001","unstructured":"Siddiqa A, Sims-Mourtada JC, Guzman-Rojas L, Rangel R, Guret C, Madrid-Marina V et al. Regulation of CD40 and CD40 ligand by the AT-hook transcription factor AKNA. Nature 2001; 410: 383\u2013387.","journal-title":"Nature"},{"key":"BFgene201460_CR9","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1089\/dna.2005.24.325","volume":"24","author":"JC Sims-Mourtada","year":"2005","unstructured":"Sims-Mourtada JC, Bruce S, McKeller MR, Rangel R, Guzman-Rojas L, Cain K et al. The human AKNA gene expresses multiple transcripts and protein isoforms as a result of alternative promoter usage, splicing, and polyadenylation. DNA Cell Biol 2005; 24: 325\u2013338.","journal-title":"DNA Cell Biol"},{"key":"BFgene201460_CR10","doi-asserted-by":"publisher","first-page":"4413","DOI":"10.1093\/nar\/26.19.4413","volume":"19","author":"L Aravid","year":"1998","unstructured":"Aravid L, Landsman D. AT-Hook motifs identified in a wide variety of DNA-binding proteins. Nucleic Acid Res 1998; 19: 4413\u20134421.","journal-title":"Nucleic Acid Res"},{"key":"BFgene201460_CR11","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1038\/cr.2011.84","volume":"21","author":"W Ma","year":"2011","unstructured":"Ma W, Ortiz-Quintero B, Rangel R, McKeller MR, Herrera-Rodriguez S, Castillo EF et al. Coordinate activation of inflammatory gene networks, alveolar destruction and neonatal death in AKNA deficient mice. Cell Res 2011; 21: 1564\u20131577.","journal-title":"Cell Res"},{"key":"BFgene201460_CR12","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1038\/cr.2011.96","volume":"21","author":"AR Moliterno","year":"2011","unstructured":"Moliterno AR, Resar LM. AKNA: another AT-hook transcription factor \u2018hooking-up\u2019 with inflammation. Cell Res 2011; 21: 1528\u20131530.","journal-title":"Cell Res"},{"key":"BFgene201460_CR13","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1101\/gr.5335506","volume":"16","author":"A Helmrich","year":"2006","unstructured":"Helmrich A, Stout-Weider K, Hermann K, Schrock E, Heiden T. Common fragile sites are conserved features of human and mouse chromosomes and relate to large active genes. Genome Res 2006; 16: 1222\u20131230.","journal-title":"Genome Res"},{"key":"BFgene201460_CR14","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1002\/humu.21078","volume":"30","author":"S Savas","year":"2009","unstructured":"Savas S, Liu G. Genetic variations as cancer prognostic markers: review and update. Hum Mutat 2009; 30: 1369\u20131377.","journal-title":"Hum Mutat"},{"key":"BFgene201460_CR15","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/S0165-4608(02)00650-7","volume":"140","author":"HT Moriarty","year":"2003","unstructured":"Moriarty HT, Webster LR. Fragile sites and bladder cancer. Cancer Genet Cytogenet 2003; 140: 89\u201398.","journal-title":"Cancer Genet Cytogenet"},{"key":"BFgene201460_CR16","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/sj.onc.1206171","volume":"22","author":"G Callahan","year":"2003","unstructured":"Callahan G, Denison SR, Phillips LA, Shridhar V, Smith DI. Characterization of the common fragile site FRA9E and its potential role in ovarian cancer. Oncogene 2003; 22: 590\u2013601.","journal-title":"Oncogene"},{"key":"BFgene201460_CR17","doi-asserted-by":"publisher","first-page":"470","DOI":"10.3109\/1354750X.2010.485332","volume":"15","author":"G Perales","year":"2010","unstructured":"Perales G, Burguete-Garc\u00eda AI, Dimas J, Bahena-Rom\u00e1n M, Berm\u00fadez-Morales VH, Moreno J et al. A polymorphism in the AT-hook motif of the transcriptional regulator AKNA is a risk factor for cervical cancer. Biomarkers 2010; 15: 470\u2013474.","journal-title":"Biomarkers"},{"key":"BFgene201460_CR18","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144: 646\u2013674.","journal-title":"Cell"},{"key":"BFgene201460_CR19","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/nature11632","volume":"491","author":"GR Abecasis","year":"2012","unstructured":"1000 Genomes Project Consortium Abecasis GR Auton A Brooks LD DePristo MA Durbin RM et al. An integrated map pf genetic variation from 1092 human genomes. Nature 2012; 491: 56\u201365.","journal-title":"Nature"},{"key":"BFgene201460_CR20","doi-asserted-by":"publisher","first-page":"e14616","DOI":"10.1371\/journal.pone.0014616","volume":"6","author":"L Mao","year":"2011","unstructured":"Mao L, Yang P, Hou S, Li F, Kijlstra A. Label-free proteomics reveals decreased expression of CD18 and AKNA in peripheral CD4+ T cells from patients with Vogt-Koyanagi-Harada syndrome. PLoS ONE 2011; 6: e14616.","journal-title":"PLoS ONE"},{"key":"BFgene201460_CR21","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/8426","volume":"5","author":"RR French","year":"1999","unstructured":"French RR, Chan HTC, Tutt AL, Glennie. MJ. CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T cell help. Nat Med 1999; 5: 548.","journal-title":"Nat Med"},{"key":"BFgene201460_CR22","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1007\/s10875-009-9279-7","volume":"29","author":"CE D\u00edaz-Ben\u00edtez","year":"2009","unstructured":"D\u00edaz-Ben\u00edtez CE, Navarro-Fuentes KR, Flores-Sosa JA, Ju\u00e1rez-D\u00edaz J, Uribe-Salas FJ, Rom\u00e1n-Basaure E et al. CD3zeta expression and T cell proliferation are inhibited by TGF-beta1 and IL-10 in cervical cancer patients. J Clin Immunol 2009; 29: 532\u2013544.","journal-title":"J Clin Immunol"},{"key":"BFgene201460_CR23","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2174\/1874357901206010241","volume":"6","author":"MH Hibma","year":"2012","unstructured":"Hibma MH. The immune response to papillomavirus during infection persistence and regression. Open Virol J 2012; 6: 241\u2013248.","journal-title":"Open Virol J"},{"key":"BFgene201460_CR24","first-page":"1021","volume":"10","author":"PE Castle","year":"2001","unstructured":"Castle PE, Hillier SL, Rabe LK, Hildesheim A, Herrero R, Bratti MC et al. An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV). Cancer Epidemiol Biomarkers Prev 2001; 10: 1021\u20131027.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"BFgene201460_CR25","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.ygyno.2006.11.023","volume":"105","author":"LS Hammes","year":"2007","unstructured":"Hammes LS, Tekmal RR, Naud P, Edelweiss MI, Kirma N, Valente PT et al. Macrophages, inflammation and risk of cervical intraepithelial neoplasia (CIN) progression-clinicopathological correlation. Gynecol Oncol 2007; 105: 157\u2013165.","journal-title":"Gynecol Oncol"},{"key":"BFgene201460_CR26","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1016\/S0140-6736(01)06809-X","volume":"358","author":"MA Nobbenhuis","year":"2001","unstructured":"Nobbenhuis MA, Helmerhorst TJ, van den Brule AJ, Rozendaal L, Voorhorst FJ, Bezemer PD et al. Cytological regression and clearance of high-risk human papillomavirus in women with an abnormal cervical smear. Lancet 2001; 358: 1782\u20131783.","journal-title":"Lancet"},{"key":"BFgene201460_CR27","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.ygyno.2005.11.039","volume":"102","author":"S Monnier-Benoit","year":"2006","unstructured":"Monnier-Benoit S, Mauny F, Riethmuller D, Guerrini JS, C\u0103p\u00eelna M, F\u00e9lix S et al. Immunohistochemical analysis of CD4+ and CD8+ T-cell subsets in high risk human papillomavirus-associated pre-malignant and malignant lesions of the uterine cervix. Gynecol Oncol 2006; 102: 22\u201331.","journal-title":"Gynecol Oncol"},{"key":"BFgene201460_CR28","doi-asserted-by":"publisher","first-page":"5449","DOI":"10.1158\/0008-5472.CAN-04-0831","volume":"64","author":"A de Jong","year":"2004","unstructured":"de Jong A, van Poelgeest MI, van der Hulst JM, Drijfhout JW, Fleuren GJ, Melief CJ et al. Human papillomavirus type 16-positive cervical cancer is associated with impaired CD4+ T-cell immunity against early antigens E2 and E6. Cancer Res 2004; 64: 5449\u20135455.","journal-title":"Cancer Res"},{"key":"BFgene201460_CR29","doi-asserted-by":"publisher","first-page":"2479","DOI":"10.1158\/1078-0432.CCR-06-2916","volume":"13","author":"S Peng","year":"2007","unstructured":"Peng S, Trimble C, Wu L, Pardoll D, Roden R, Hung CF et al. HLA-DQB1*02-restricted HPV-16 E7 peptide-specific CD4+ T-cell immune responses correlate with regression of HPV-16-associated high-grade squamous intraepithelial lesions. Clin Cancer Res 2007; 13: 2479\u20132487.","journal-title":"Clin Cancer Res"},{"key":"BFgene201460_CR30","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/ijc.24804","volume":"126","author":"YL Woo","year":"2010","unstructured":"Woo YL, van den Hende M, Sterling JC, Coleman N, Crawford A, Kwappenberg KM et al. A prospective study on the natural course of low-grade squamous intraepithelial lesions and the presence of HPV16 E2-, E6- and E7-specific T-cell responses. Int J Cancer 2010; 126: 133\u2013141.","journal-title":"Int J Cancer"},{"key":"BFgene201460_CR31","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1089\/vim.2006.19.481","volume":"19","author":"JM Alcocer-Gonzalez","year":"2006","unstructured":"Alcocer-Gonzalez JM, Berumen J, Tamez-Guerra R, Bermudez-Morales VH, Peralta-Zaragoza O, Hernandez-Pando R et al. In vivo expression of immunosuppressive cytokines in human papillomavirus-transformed cancer cells. Viral Immunol 2006; 19: 481\u2013491.","journal-title":"Viral Immunol"},{"key":"BFgene201460_CR32","doi-asserted-by":"publisher","first-page":"581","DOI":"10.3390\/v4040581","volume":"4","author":"N Papic","year":"2012","unstructured":"Papic N, Maxwell CI, Delker DA, Liu S, Heale BS, Hagedorn CH. RNA-sequencing analysis of 5' capped RNAs identifies many new differentially expressed genes in acute hepatitis C virus infection. Viruses 2012; 4: 581\u2013612.","journal-title":"Viruses"},{"key":"BFgene201460_CR33","doi-asserted-by":"crossref","first-page":"4140","DOI":"10.4049\/jimmunol.162.7.4140","volume":"162","author":"A Altenburg","year":"1999","unstructured":"Altenburg A, Baldus SE, Smola H, Pfister H, Hess S. CD40 ligand-CD40 interaction induces chemokines in cervical carcinoma cells in synergism with IFN-gamma. J Immunol 1999; 162: 4140\u20134147.","journal-title":"J Immunol"},{"key":"BFgene201460_CR34","doi-asserted-by":"publisher","first-page":"41","DOI":"10.4049\/jimmunol.174.1.41","volume":"174","author":"SC Hill","year":"2005","unstructured":"Hill SC, Youde SJ, Man S, Teale GR, Baxendale AJ, Hislop A et al. Activation of CD40 in cervical carcinoma cells facilitates CTL responses and augments chemotherapy-induced apoptosis. J Immunol 2005; 174: 41\u201350.","journal-title":"J Immunol"},{"key":"BFgene201460_CR35","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.canep.2010.12.004","volume":"35","author":"Q Huang","year":"2011","unstructured":"Huang Q, Qu QX, Xie F, Zhang T, Hu JM, Chen YG et al. CD40 is overexpressed by HPV16\/18-E6 positive cervical carcinoma and correlated with clinical parameters and vascular density. Cancer Epidemiol 2011; 35: 388\u2013392.","journal-title":"Cancer Epidemiol"},{"key":"BFgene201460_CR36","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/cam4.192","volume":"3","author":"D Chen","year":"2014","unstructured":"Chen D, Gyllensten U. A cis-eQTL of HLA-DRB1 and a frameshift mutation of MICA contribute to the pattern of association of HLA alleles with cervical cancer. Cancer Med 2014; 3: 445\u2013452.","journal-title":"Cancer Med"},{"key":"BFgene201460_CR37","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s11568-011-9155-4","volume":"5","author":"BL Jones","year":"2011","unstructured":"Jones BL, Swallow DM. The impact of cis-acting polymorphisms on the human phenotype. Hugo J 2011; 5: 13\u201323.","journal-title":"Hugo J"},{"key":"BFgene201460_CR38","first-page":"3610","volume":"55","author":"R Hromas","year":"1995","unstructured":"Hromas R, Morris J, Cornetta K, Berebitsky D, Davidson A, Sha M et al. Aberrant expression of the Myeloid Zinc Finger gene, MZF-1, is oncogenic. Cancer Res 1995; 55: 3610\u20133614.","journal-title":"Cancer Res"},{"key":"BFgene201460_CR39","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1101\/gad.902301","volume":"15","author":"M Gaboli","year":"2001","unstructured":"Gaboli M, Kotsi PA, Gurrieri C, Cattoretti G, Ronchetti S, Cordon-Cardo C et al. Mzf1 controls cell proliferation and tumorigenesis. Genes Dev 2001; 15: 1625\u20131630.","journal-title":"Genes Dev"},{"key":"BFgene201460_CR40","doi-asserted-by":"publisher","first-page":"e55749","DOI":"10.1371\/journal.pone.0055749","volume":"8","author":"A Albergaria","year":"2013","unstructured":"Albergaria A, Resende C, Nobre AR, Ribeiro AS, Sousa B, Machado JC et al. CCAAT\/enhancer binding protein \u03b2 (C\/EBP\u03b2) isoforms as transcriptional regulators of the pro-invasive CDH3\/P-cadherin gene in human breast cancer cells. PLoS ONE 2013; 8: e55749.","journal-title":"PLoS ONE"},{"key":"BFgene201460_CR41","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/(SICI)1097-0215(20000501)86:3<337::AID-IJC6>3.0.CO;2-3","volume":"86","author":"K Rask","year":"2000","unstructured":"Rask K, Th\u00f6rn M, Pont\u00e9n F, Kraaz W, Sundfeldt K, Hedin L et al. Increased expression of the transcription factors CCAAT-enhancer binding protein-beta(C\/EBBeta) and C\/EBzeta (CHOP) correlate with invasiveness of human colorectal cancer. Int J Cancer 2000; 86: 337\u2013343.","journal-title":"Int J Cancer"},{"key":"BFgene201460_CR42","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.bbrc.2012.07.125","volume":"425","author":"SJ Tsai","year":"2012","unstructured":"Tsai SJ, Hwang JM, Hsieh SC, Ying TH, Hsieh YH. Overexpression of myeloid zinc finger 1 suppresses matrix metalloproteinase-2 expression and reduces invasiveness of SiHa human cervical cancer cells. Biochem Biophys Res Commun 2012; 425: 462\u2013467.","journal-title":"Biochem Biophys Res Commun"},{"key":"BFgene201460_CR43","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1750-9378-7-32","volume":"7","author":"K Torres-Poveda","year":"2012","unstructured":"Torres-Poveda K, Burguete-Garc\u00eda AI, Cruz M, Mart\u00ednez-Nava GA, Bahena-Rom\u00e1n M, Ort\u00edz-Flores E et al. The SNP at \u2212592 of human IL-10 gene is associated with serum IL-10 levels and increased risk for human papillomavirus cervical lesion development. Infect Agent Cancer 2012; 7: 32.","journal-title":"Infect Agent Cancer"},{"key":"BFgene201460_CR44","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/S0097-8485(01)00099-7","volume":"26","author":"MG Reese","year":"2001","unstructured":"Reese MG. Application of a time-delay neural network to promoter annotation in the Drosophila melanogaster genome. Comput Chem 2001; 26: 51\u201356.","journal-title":"Comput Chem"},{"key":"BFgene201460_CR45","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1186\/1471-2105-8-481","volume":"8","author":"VG Levitsky","year":"2007","unstructured":"Levitsky VG, Ignatieva EV, Ananko EA, Turnaev II, Merkulova TI, Kolchanov NA et al. Effective transcription factor binding site prediction using a combination of optimization, a genetic algorithm and discriminant analysis to capture distant interactions. BMC Bioinformatics 2007; 8: 481.","journal-title":"BMC Bioinformatics"},{"key":"BFgene201460_CR46","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1093\/nar\/26.1.362","volume":"26","author":"T Heinemeyer","year":"1998","unstructured":"Heinemeyer T, Wingender E, Reuter I, Hermjakob H, Kel AE, Kel OV et al. Databases on transcriptional regulation: TRANSFAC, TRRD, and COMPEL. Nucleic Acids Res 1998; 26: 364\u2013370.","journal-title":"Nucleic Acids Res"},{"issue":"Web Server issu","key":"BFgene201460_CR47","doi-asserted-by":"publisher","first-page":"W432","DOI":"10.1093\/nar\/gki441","volume":"33","author":"DS Chekmenev","year":"2005","unstructured":"Chekmenev DS, Haid C, Kel AE. P-Match: transcription factor binding site search by combining patterns and weight matrices. Nucleic Acids Res 2005; 33 (Web Server issue): W432\u2013W437.","journal-title":"Nucleic Acids Res"},{"key":"BFgene201460_CR48","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1093\/nar\/29.1.308","volume":"29","author":"ST Sherry","year":"2001","unstructured":"Sherry ST, Ward MH, Kholodov M, Baker J, Phan L, Smigielski EM et al. dbSNP: the NCBI database of genetic variation. Nucleic Acids Res 2001; 29: 308\u2013311.","journal-title":"Nucleic Acids Res"},{"issue":"Database issue","key":"BFgene201460_CR49","first-page":"D48","volume":"41","author":"P Flicek","year":"2013","unstructured":"Flicek P, Ahmed I, Amode MR, Barrell D, Beal K, Brent S et al. Ensembl 2013. Nucleic Acids Res 2013; 41 (Database issue): D48\u2013D55.","journal-title":"Nucleic Acids Res"},{"key":"BFgene201460_CR50","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1093\/hmg\/ddn022","volume":"17","author":"X Chen","year":"2008","unstructured":"Chen X, Weaver J, Bove BA, Vanderveer LA, Weil SC, Miron A et al. Allelic imbalance in BRCA1 and BRCA2 gene expression is associated with an increased breast cancer risk. Hum Mol Genet 2008; 17: 1336\u20131348.","journal-title":"Hum Mol Genet"},{"key":"BFgene201460_CR51","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/genetics\/49.1.49","volume":"49","author":"RC Lewontin","year":"1964","unstructured":"Lewontin RC. The interaction of selection and linkage. I. General considerations; heterotic models. Genetics 1964; 49: 49\u201367.","journal-title":"Genetics"}],"container-title":["Genes &amp; Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/gene201460.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gene201460","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gene201460.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T22:25:04Z","timestamp":1689632704000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/gene201460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,6]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["BFgene201460"],"URL":"https:\/\/doi.org\/10.1038\/gene.2014.60","relation":{},"ISSN":["1466-4879","1476-5470"],"issn-type":[{"value":"1466-4879","type":"print"},{"value":"1476-5470","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,6]]},"assertion":[{"value":"27 June 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}